Cytogen completes Cellcor purchase
Monoclonal antibody firm Cytogen of Princeton, NJ, has completedits purchase of Cellcor, a biotech therapy developer based inNewton, MA (SCAN 7/19/95). Cellcor has been merged into Cytogenas a wholly owned subsidiary, Cytogen
Monoclonal antibody firm Cytogen of Princeton, NJ, has completedits purchase of Cellcor, a biotech therapy developer based inNewton, MA (SCAN 7/19/95). Cellcor has been merged into Cytogenas a wholly owned subsidiary, Cytogen said.
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Recent Videos
Related Content
